Review article: angiogenesis soluble factors as liver disease markers

Authors


Dr R. Moreno-Otero, Unidad de Hepatología (planta 3), Hospital Universitario de la Princesa, Diego de León 62, E-28006-Madrid, Spain.
E-mail: rmoreno.hlpr@salud.madrid.org

Summary

Angiogenesis is the formation of new blood vessels from pre-existing ones; it has been studied at the molecular level in different pathologies and is currently considered a promising novel therapeutic target in cancer. Recently, the use of angiogenesis soluble factors as markers of tumour growth has been investigated. The knowledge gained has led to test their use as therapeutic agents. Additionally, angiogenesis soluble factors could be used for the follow-up of pathologies that currently require monitoring with invasive techniques, like chronic viral hepatitis or renal and haematological diseases. The different factors have been described in multiple studies. In some cases, such as hepatocellular carcinoma, a potential use as prognostic markers has been suggested.

Ancillary